These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17142309)

  • 1. Novel patterns of genome rearrangement and their association with survival in breast cancer.
    Hicks J; Krasnitz A; Lakshmi B; Navin NE; Riggs M; Leibu E; Esposito D; Alexander J; Troge J; Grubor V; Yoon S; Wigler M; Ye K; Børresen-Dale AL; Naume B; Schlicting E; Norton L; Hägerström T; Skoog L; Auer G; Månér S; Lundin P; Zetterberg A
    Genome Res; 2006 Dec; 16(12):1465-79. PubMed ID: 17142309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution ROMA CGH and FISH analysis of aneuploid and diploid breast tumors.
    Hicks J; Muthuswamy L; Krasnitz A; Navin N; Riggs M; Grubor V; Esposito D; Alexander J; Troge J; Wigler M; Maner S; Lundin P; Zetterberg A
    Cold Spring Harb Symp Quant Biol; 2005; 70():51-63. PubMed ID: 16869738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
    Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
    Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
    Isola JJ; Kallioniemi OP; Chu LW; Fuqua SA; Hilsenbeck SG; Osborne CK; Waldman FM
    Am J Pathol; 1995 Oct; 147(4):905-11. PubMed ID: 7573366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
    Parris TZ; Danielsson A; Nemes S; Kovács A; Delle U; Fallenius G; Möllerström E; Karlsson P; Helou K
    Clin Cancer Res; 2010 Aug; 16(15):3860-74. PubMed ID: 20551037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of DNA amplification on gene expression patterns in breast cancer.
    Hyman E; Kauraniemi P; Hautaniemi S; Wolf M; Mousses S; Rozenblum E; Ringnér M; Sauter G; Monni O; Elkahloun A; Kallioniemi OP; Kallioniemi A
    Cancer Res; 2002 Nov; 62(21):6240-5. PubMed ID: 12414653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.
    Lucito R; Healy J; Alexander J; Reiner A; Esposito D; Chi M; Rodgers L; Brady A; Sebat J; Troge J; West JA; Rostan S; Nguyen KC; Powers S; Ye KQ; Olshen A; Venkatraman E; Norton L; Wigler M
    Genome Res; 2003 Oct; 13(10):2291-305. PubMed ID: 12975311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
    Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
    Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated profiling of basal and luminal breast cancers.
    Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
    Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between genomic alterations assessed by array comparative genomic hybridization, prognostically informative histologic subtype, stage, and patient survival in gastric cancer.
    Rossi E; Klersy C; Manca R; Zuffardi O; Solcia E
    Hum Pathol; 2011 Dec; 42(12):1937-45. PubMed ID: 21676433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.
    Baumbusch LO; Aarøe J; Johansen FE; Hicks J; Sun H; Bruhn L; Gunderson K; Naume B; Kristensen VN; Liestøl K; Børresen-Dale AL; Lingjaerde OC
    BMC Genomics; 2008 Aug; 9():379. PubMed ID: 18691401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.